AG100
Human IgG Fc Control Protein, recombinant protein
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.42
Recommended Products
biological source
human
Quality Level
Assay
>90% (Coomassie blue staining, SDS-PAGE)
manufacturer/tradename
Chemicon®
concentration
1 mg/mL
shipped in
dry ice
General description
Product Source: Mammalian cells, HEK293 cell line
Recombinatant fusion proteins consisting of the extracellular domain of immunoregulatory proteins and the constant (Fc) domain of immunoglobulin G (IgG) represent a growing class of human therapeutics. Chimeric protein of Human target protein and Human IgG-Fc domain can be purified using protein A chromatography.
This product is the control protein, Human IgG-Fc domain, purified using protein A-agarose (Millipore Corp, cat. # 16-125). MW ~ 55 kDa.
This product is the control protein, Human IgG-Fc domain, purified using protein A-agarose (Millipore Corp, cat. # 16-125). MW ~ 55 kDa.
Application
Research Category
All
All
This product should be used as the control protein in the activity test of chimeric protein of Human target protein and Human IgG-Fc domain.
Other applications of Human IgG-Fc domain.
Other applications of Human IgG-Fc domain.
Packaging
Active, as purified using protein A-agarose (Millipore Corp, cat. # 16-125).
Physical form
50µg of recombinant protein in 50µl of 1X PBS, 20%(v/v) glycerol. Frozen solution.
Storage and Stability
Shipped on dry ice. Best stored at -80 C for up to 6 months after date of receipt. Thawed aliquots should be used immediately, as repeated freeze/thaw cycles might result in loss of activity.
Analysis Note
Western blotting by primary antibody Mouse anti-Human IgG, clone HP6017, Fc (Millipore Corp, cat.# MAB1302) and secondary antibody Goat anti-Mouse IgG, HRP conjugate (Millipore Corp, cat.# 12-349).
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class Code
10 - Combustible liquids
WGK
WGK 2
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli.
Laura Paix?o,Liliana Rodrigues,Isabel Couto,Marta Martins,Pedro Fernandes et al.
Journal of Biological Engineering null
Luke P Randall et al.
The Journal of antimicrobial chemotherapy, 56(2), 297-306 (2005-06-16)
To determine the efficacy of enrofloxacin (Baytril) in chickens in eradicating three different resistance phenotypes of Salmonella enterica and to examine the resistance mechanisms of resulting mutants. In two separate replicate experiments (I and II), three strains of Salmonella enterica
Transketolase A, an enzyme in central metabolism, derepresses the marRAB multiple antibiotic resistance operon of Escherichia coli by interaction with MarR.
Francis Domain,Xiaowen R Bina,Stuart B Levy
Molecular Microbiology null
Mark A Webber et al.
Antimicrobial agents and chemotherapy, 49(10), 4390-4392 (2005-09-29)
Fluoroquinolone-resistant Escherichia coli isolates which overexpressed acrB and had a substitution at amino acid 45 of AcrR were complemented with wild-type acrR. Complementation led to increased sensitivity to ciprofloxacin and to ethidium bromide, suggesting that mutation at amino acid 45
Fei Zhang et al.
Journal of medical virology, 93(12), 6671-6685 (2021-07-30)
Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a wide spectrum of syndromes involving multiple organ systems and is primarily mediated by viral spike (S) glycoprotein through the receptor-binding domain (RBD) and numerous cellular proteins including ACE2, transmembrane
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service